In the 72-week non-diabetic obesity trial, adults lost -15.0% at 5 mg, -19.5% at 10 mg, and -20.9% at 15 mg. Real-world outcomes vary because dose reached, adherence, and baseline state vary
*The information presented in this article is provided solely for scientific, educational, and laboratory reference purposes
Researchers investigating nervous-system optimization and restorative biological communication frequently include DSIP in advanced studies
On the other side, long-term human safety data, standardized dosing protocols, and controlled efficacy trials remain extremely limited
This peptide demonstrates remarkable stability and exhibits pleiotropic effects throughout various tissue systems
The powder should dissolve within 30 to 60 seconds